Rising Trends in Pancreatic Cancer Incidence and Mortality in 2000-2014

Overview

Journal Clin Epidemiol

Publisher Dove Medical Press

Specialty Public Health

Date 2018 Jul 20

PMID 30022856

Citations 42

Authors

Wenrui Wu

Xingkang He

Liya Yang

Qing Wang

Xiaoyuan Bian

Jianzhong Ye

Yating Li

Lanjuan Li

Affiliations

Soon will be listed here.

Abstract

Background: The morbidity and mortality of pancreatic cancer vary considerably around the world. The aim of this study was to characterize and evaluate recent changes in incidence and incidence-based mortality in the USA.

Methods: Incidence and incidence-based mortality data were based on the 18 Surveillance, Epidemiology, and End Results (SEER) registries through SEERStat software. We adopted joinpoint regression to analyze the temporal trends stratified by age, gender, ethnicity, stage, tumor site, and size.

Results: Based on 18 SEER data sets, the age-adjusted incidence of pancreatic cancer increased from 11.85/100,000 in 2000 to 14.70/100,000 in 2014, increasing by an average annual percentage change (AAPC) of 1.6 (95% CI 1.5-1.8, <0.05). The incidence-based mortality also increased, from 9.96/100,000 in 2001 to 12.96/100,000 in 2014, increasing by an AAPC of 1.9 (95% CI 1.3-2.5, <0.05). However, we observed a deceleration in mortality since 2005, with the annual percentage change decreasing from 4.1 (2001-2005) to 1.0 (2005-2014). These increasing trends in pancreatic cancer were observed in most subgroups (stratified by age, gender, ethnicity, stage, tumor site, and size).

Conclusion: The incidence and mortality rates of pancreatic cancer in the USA have increased significantly since 2000, highlighting the need for increased preventive, screening, and surveillance efforts.

Citing Articles

Cell Membrane Fatty Acids and PIPs Modulate the Etiology of Pancreatic Cancer by Regulating AKT.

Torres C, Mancinelli G, Chen J, Cordoba-Chacon J, Pins D, Saeed S Nutrients. 2025; 17(1).

PMID: 39796583 PMC: 11722924. DOI: 10.3390/nu17010150.

The epidemiological trends and predictions of esophageal squamous cell carcinoma and gastroesophageal junction carcinoma: an Australian population-based study.

Bohingamu Mudiyanselage S, Nguyen D, Tang B, Williams R, Kamal M, Zhao F BMC Cancer. 2024; 24(1):1498.

PMID: 39639209 PMC: 11619256. DOI: 10.1186/s12885-024-13151-3.

Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weighting.

Imaoka H, Ikeda M, Kobayashi S, Ohba A, Ueno M, Suzuki Y J Gastroenterol. 2024; 60(3):356-367.

PMID: 39614927 PMC: 11880175. DOI: 10.1007/s00535-024-02186-9.

Trend and forecast analysis of the changing disease burden of pancreatic cancer attributable to high fasting glucose in China, 1990-2021.

Song L, Chen Z, Li Y, Ran L, Liao D, Zhang Y Front Oncol. 2024; 14:1471699.

PMID: 39493456 PMC: 11527594. DOI: 10.3389/fonc.2024.1471699.

Incidence Rates and Time Trends of Pancreatic Cancer in the Golestan Province, Northeastern Iran, 2006-2019.

Kaabe S, Amiriani T, Teimoorian M, Besharat S, Salamat F, Hasanpour-Heidari S Arch Iran Med. 2024; 27(9):486-493.

PMID: 39465523 PMC: 11496600. DOI: 10.34172/aim.31168.

References

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

Wood H, Gupta S, Kang J, Quinn M, Maxwell J, Mudan S . Pancreatic cancer in England and Wales 1975-2000: patterns and trends in incidence, survival and mortality. Aliment Pharmacol Ther. 2006; 23(8):1205-14. DOI: 10.1111/j.1365-2036.2006.02860.x. View

Bosetti C, Lucenteforte E, Silverman D, Petersen G, Bracci P, Ji B . Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol. 2011; 23(7):1880-8. PMC: 3387822. DOI: 10.1093/annonc/mdr541. View

Hidalgo M, Cascinu S, Kleeff J, Labianca R, Lohr J, Neoptolemos J . Addressing the challenges of pancreatic cancer: future directions for improving outcomes. Pancreatology. 2014; 15(1):8-18. DOI: 10.1016/j.pan.2014.10.001. View

Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, Barzi F, Woodward M . Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer. 2005; 92(11):2076-83. PMC: 2361795. DOI: 10.1038/sj.bjc.6602619. View

Bouvier A, Uhry Z, Jooste V, Drouillard A, Remontet L, Launoy G . Focus on an unusual rise in pancreatic cancer incidence in France. Int J Epidemiol. 2017; 46(6):1764-1772. PMC: 5837593. DOI: 10.1093/ije/dyx088. View

Chen W, Liang D, Zhang S, Zheng R, He Y . Pancreatic cancer incidence and mortality patterns in china, 2009. Asian Pac J Cancer Prev. 2014; 14(12):7321-4. DOI: 10.7314/apjcp.2013.14.12.7321. View

Siegel R, Miller K, Jemal A . Cancer Statistics, 2017. CA Cancer J Clin. 2017; 67(1):7-30. DOI: 10.3322/caac.21387. View

Rebelo A, Molpeceres J, Rijo P, Reis C . Pancreatic Cancer Therapy Review: From Classic Therapeutic Agents to Modern Nanotechnologies. Curr Drug Metab. 2017; 18(4):346-359. DOI: 10.2174/1389200218666170201151135. View

10.

Willett W . Diet and cancer. Oncologist. 2000; 5(5):393-404. DOI: 10.1634/theoncologist.5-5-393. View

11.

Zheng T, Holford T, Ward B, McKay L, Flannery J, Boyle P . Time trend in pancreatic cancer incidence in Connecticut, 1935-1990. Int J Cancer. 1995; 61(5):622-7. DOI: 10.1002/ijc.2910610507. View

12.

Ilic M, Ilic I . Epidemiology of pancreatic cancer. World J Gastroenterol. 2016; 22(44):9694-9705. PMC: 5124974. DOI: 10.3748/wjg.v22.i44.9694. View

13.

Manzur A, Oluwasanmi A, Moss D, Curtis A, Hoskins C . Nanotechnologies in Pancreatic Cancer Therapy. Pharmaceutics. 2017; 9(4). PMC: 5750645. DOI: 10.3390/pharmaceutics9040039. View

14.

Vajdic C, Laaksonen M . Commentary: Unusual pancreatic cancer incidence and mortality patterns. Int J Epidemiol. 2017; 46(6):1772-1773. DOI: 10.1093/ije/dyx142. View

15.

Kamisawa T, Wood L, Itoi T, Takaori K . Pancreatic cancer. Lancet. 2016; 388(10039):73-85. DOI: 10.1016/S0140-6736(16)00141-0. View

16.

Ezzati M, Henley S, Lopez A, Thun M . Role of smoking in global and regional cancer epidemiology: current patterns and data needs. Int J Cancer. 2005; 116(6):963-71. DOI: 10.1002/ijc.21100. View

17.

Agarwal B, Correa A, Ho L . Survival in pancreatic carcinoma based on tumor size. Pancreas. 2008; 36(1):e15-20. DOI: 10.1097/mpa.0b013e31814de421. View

18.

Kim H, Fay M, Feuer E, Midthune D . Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19(3):335-51. DOI: 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z. View

19.

Ma J, Siegel R, Jemal A . Pancreatic cancer death rates by race among US men and women, 1970-2009. J Natl Cancer Inst. 2013; 105(22):1694-700. DOI: 10.1093/jnci/djt292. View

20.

Weiss W, Benarde M . The temporal relation between cigarette smoking and pancreatic cancer. Am J Public Health. 1983; 73(12):1403-4. PMC: 1651259. DOI: 10.2105/ajph.73.12.1403. View